JD Health International, Inc.

As of June 30, 2026, JD Health International, Inc. carries a market capitalization of 104.74B, placing it among publicly traded companies globally. Its enterprise value stands at 48.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

JD Health International, Inc.'s next confirmed earnings release is scheduled for March 29, 2027.

As of June 30, 2026, JD Health International, Inc. has 3.19B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, JD Health International, Inc. maintains a current ratio of 2.69, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, JD Health International, Inc.'s stock has declined approximately 38.59% over the past 52 weeks. The 50-day moving average sits at 36.67, while the 200-day moving average is 44.96.

As of June 30, 2026, JD Health International, Inc. holds 56.95B in cash and equivalents against 1.01B in total debt, resulting in a net debt position of -23.63B. Total book value stands at 71.03B, with working capital of 42.15B providing operational flexibility.